Related stories
Evonik Sees 2026 Adjusted EBITDA in Upper Half of €2.0B–€2.2B Range
M impact | EARNINGS | Nov 03, 2026, 06:04 AM UTC
Vivo Reports FY2025 Loss
Vivo reported a FY2025 loss attributable to shareholders, down 217.61% year over year, with negative basic EPS.
M impact | EARNINGS | Nov 03, 2026, 05:50 AM UTC
أرباح أرامكو ترتفع 34.5% في الربع الثالث رغم الهجمات
M impact | EARNINGS | Nov 03, 2026, 05:47 AM UTC
Evonik Q3 adjusted EBITDA rises 40% to €629 million
M impact | EARNINGS | Nov 03, 2026, 05:45 AM UTC
Evonik Raises Operating Profit and Turns More Optimistic
M impact | EARNINGS | Nov 03, 2026, 05:45 AM UTC
Evonik Q3 sales rise 13% year over year to €3.83 billion
M impact | EARNINGS | Nov 03, 2026, 05:45 AM UTC